Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
D000203:Activities of Daily Living; D000631:Aminopyridines / Q000008:administration & dosage* / Q000009:adverse effects; D000676:Amrinone; D000818:Animals; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D002415:Cats; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects
D000631:Aminopyridines; D002316:Cardiotonic Agents; D000676:Amrinone